{"entity":{"type":"insider","cik":"0001831410","url":"/insider/0001831410","json_url":"/insider/0001831410.json","name":"Harmon Cyrus","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":51,"n_filings":31,"first":"2021-06-21","last":"2026-07-27","span_basis":"filed_date"},"name_variants":[{"name":"Harmon Cyrus","source":"filing","n_filings":31,"first_seen":"2021-06-21","last_seen":"2026-07-27"}],"transactions":[{"id":5818955,"accession":"0001831410-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001831410-26-000008","line_url":"/filing/0001831410-26-000008#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":11.714,"price_display":"11.71","price_state":"stated","total_value":146425.0,"total_display":"146,425.00","total_whole":"146,425","shares_owned_after":702770.0,"shares_owned_after_display":"702,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-27","scope":"insider"},{"id":5818953,"accession":"0001831410-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001831410-26-000008","line_url":"/filing/0001831410-26-000008#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":11.579,"price_display":"11.58","price_state":"stated","total_value":144737.5,"total_display":"144,737.50","total_whole":"144,738","shares_owned_after":715270.0,"shares_owned_after_display":"715,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-23","filed_date":"2026-07-27","scope":"insider"},{"id":5753419,"accession":"0001831410-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001831410-26-000004","line_url":"/filing/0001831410-26-000004#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.88,"price_display":"26.88","price_state":"stated","total_value":268800.0,"total_display":"268,800.00","total_whole":"268,800","shares_owned_after":727770.0,"shares_owned_after_display":"727,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":5996983,"accession":"0001831410-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001831410-26-000002","line_url":"/filing/0001831410-26-000002#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3489.0,"shares_display":"3,489","price_per_share":29.12,"price_display":"29.12","price_state":"stated","total_value":101599.68,"total_display":"101,599.68","total_whole":"101,600","shares_owned_after":737770.0,"shares_owned_after_display":"737,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-14","filed_date":"2026-01-16","scope":"insider"},{"id":4103288,"accession":"0001831410-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001831410-25-000007","line_url":"/filing/0001831410-25-000007#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2881.0,"shares_display":"2,881","price_per_share":28.53,"price_display":"28.53","price_state":"stated","total_value":82194.93,"total_display":"82,194.93","total_whole":"82,195","shares_owned_after":741259.0,"shares_owned_after_display":"741,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-22","filed_date":"2025-12-29","scope":"insider"},{"id":4053523,"accession":"0001831410-25-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001831410-25-000004","line_url":"/filing/0001831410-25-000004","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13086.0,"shares_display":"13,086","price_per_share":8.327641754546844,"price_display":"8.33","price_state":"stated","total_value":108975.52,"total_display":"108,975.52","total_whole":"108,976","shares_owned_after":744140.0,"shares_owned_after_display":"744,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-18","scope":"insider","n_lines":2},{"id":4053521,"accession":"0001831410-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001831410-25-000004","line_url":"/filing/0001831410-25-000004","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11914.0,"shares_display":"11,914","price_per_share":8.046426053382575,"price_display":"8.05","price_state":"stated","total_value":95865.12,"total_display":"95,865.12","total_whole":"95,865","shares_owned_after":754140.0,"shares_owned_after_display":"754,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider","n_lines":2},{"id":2900907,"accession":"0001415889-24-029028","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-029028","line_url":"/filing/0001415889-24-029028","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8137.0,"shares_display":"8,137","price_per_share":8.676058744008849,"price_display":"8.68","price_state":"stated","total_value":70597.09,"total_display":"70,597.09","total_whole":"70,597","shares_owned_after":764319.0,"shares_owned_after_display":"764,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-11","scope":"insider","n_lines":2},{"id":2900902,"accession":"0001415889-24-029028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-029028","line_url":"/filing/0001415889-24-029028#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8256.0,"shares_display":"8,256","price_per_share":9.37,"price_display":"9.37","price_state":"stated","total_value":77358.72,"total_display":"77,358.72","total_whole":"77,359","shares_owned_after":772277.0,"shares_owned_after_display":"772,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-11","scope":"insider"},{"id":2900265,"accession":"0001415889-24-020461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-020461","line_url":"/filing/0001415889-24-020461#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":934.0,"shares_display":"934","price_per_share":15.55,"price_display":"15.55","price_state":"stated","total_value":14523.7,"total_display":"14,523.70","total_whole":"14,524","shares_owned_after":751283.0,"shares_owned_after_display":"751,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-30","filed_date":"2024-07-31","scope":"insider"},{"id":2900262,"accession":"0001415889-24-020461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-020461","line_url":"/filing/0001415889-24-020461#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4066.0,"shares_display":"4,066","price_per_share":15.58,"price_display":"15.58","price_state":"stated","total_value":63348.28,"total_display":"63,348.28","total_whole":"63,348","shares_owned_after":752217.0,"shares_owned_after_display":"752,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-29","filed_date":"2024-07-31","scope":"insider"},{"id":2279078,"accession":"0001415889-24-019528","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019528","line_url":"/filing/0001415889-24-019528#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.26,"price_display":"12.26","price_state":"stated","total_value":61300.0,"total_display":"61,300.00","total_whole":"61,300","shares_owned_after":756283.0,"shares_owned_after_display":"756,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-12","scope":"insider"},{"id":2530398,"accession":"0001415889-24-018975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-018975","line_url":"/filing/0001415889-24-018975#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":10.77,"price_display":"10.77","price_state":"stated","total_value":215400.0,"total_display":"215,400.00","total_whole":"215,400","shares_owned_after":761283.0,"shares_owned_after_display":"761,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-28","filed_date":"2024-07-02","scope":"insider"},{"id":2755499,"accession":"0001415889-24-015508","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-015508","line_url":"/filing/0001415889-24-015508#line-3","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.33,"price_display":"12.33","price_state":"stated","total_value":61650.0,"total_display":"61,650.00","total_whole":"61,650","shares_owned_after":781283.0,"shares_owned_after_display":"781,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-04","filed_date":"2024-06-04","scope":"insider"},{"id":2755488,"accession":"0001415889-24-015508","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-015508","line_url":"/filing/0001415889-24-015508#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.93,"price_display":"10.93","price_state":"stated","total_value":54650.0,"total_display":"54,650.00","total_whole":"54,650","shares_owned_after":786283.0,"shares_owned_after_display":"786,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider"},{"id":2755482,"accession":"0001415889-24-015508","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015508","line_url":"/filing/0001415889-24-015508#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":141150.0,"total_display":"141,150.00","total_whole":"141,150","shares_owned_after":791283.0,"shares_owned_after_display":"791,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-04","scope":"insider"},{"id":3262461,"accession":"0001415889-24-012485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-012485","line_url":"/filing/0001415889-24-012485#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":54600.0,"total_display":"54,600.00","total_whole":"54,600","shares_owned_after":806283.0,"shares_owned_after_display":"806,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-07","scope":"insider"},{"id":3262356,"accession":"0001415889-24-012020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-012020","line_url":"/filing/0001415889-24-012020#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":9.51,"price_display":"9.51","price_state":"stated","total_value":142650.0,"total_display":"142,650.00","total_whole":"142,650","shares_owned_after":811283.0,"shares_owned_after_display":"811,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-30","filed_date":"2024-05-02","scope":"insider"},{"id":2329445,"accession":"0001415889-24-009445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009445","line_url":"/filing/0001415889-24-009445#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":219400.0,"total_display":"219,400.00","total_whole":"219,400","shares_owned_after":826283.0,"shares_owned_after_display":"826,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-03-29","scope":"insider"},{"id":3052865,"accession":"0001415889-24-006322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-006322","line_url":"/filing/0001415889-24-006322","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":12.41236,"price_display":"12.41","price_state":"stated","total_value":310309.0,"total_display":"310,309.00","total_whole":"310,309","shares_owned_after":846383.0,"shares_owned_after_display":"846,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider","n_lines":2},{"id":2324488,"accession":"0001415889-24-002350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-002350","line_url":"/filing/0001415889-24-002350#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.56,"price_display":"15.56","price_state":"stated","total_value":77800.0,"total_display":"77,800.00","total_whole":"77,800","shares_owned_after":871283.0,"shares_owned_after_display":"871,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider"},{"id":2324486,"accession":"0001415889-24-002350","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-002350","line_url":"/filing/0001415889-24-002350#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":12.23,"price_display":"12.23","price_state":"stated","total_value":305750.0,"total_display":"305,750.00","total_whole":"305,750","shares_owned_after":876283.0,"shares_owned_after_display":"876,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":2947772,"accession":"0001415889-24-000070","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000070","line_url":"/filing/0001415889-24-000070","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":13.38,"price_display":"13.38","price_state":"stated","total_value":334500.0,"total_display":"334,500.00","total_whole":"334,500","shares_owned_after":903783.0,"shares_owned_after_display":"903,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-29","filed_date":"2024-01-02","scope":"insider","n_lines":2},{"id":7875953,"accession":"0001415889-23-015701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-015701","line_url":"/filing/0001415889-23-015701#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":12.57,"price_display":"12.57","price_state":"stated","total_value":314250.0,"total_display":"314,250.00","total_whole":"314,250","shares_owned_after":926283.0,"shares_owned_after_display":"926,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-01","scope":"insider"},{"id":8480166,"accession":"0001415889-23-015457","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-23-015457","line_url":"/filing/0001415889-23-015457#line-3","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3989.0,"shares_display":"3,989","price_per_share":13.9,"price_display":"13.90","price_state":"stated","total_value":55447.1,"total_display":"55,447.10","total_whole":"55,447","shares_owned_after":951283.0,"shares_owned_after_display":"951,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-22","scope":"insider"},{"id":8480162,"accession":"0001415889-23-015457","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-015457","line_url":"/filing/0001415889-23-015457#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4192.0,"shares_display":"4,192","price_per_share":14.86,"price_display":"14.86","price_state":"stated","total_value":62293.12,"total_display":"62,293.12","total_whole":"62,293","shares_owned_after":955272.0,"shares_owned_after_display":"955,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":8665697,"accession":"0001415889-23-014714","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-014714","line_url":"/filing/0001415889-23-014714#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.64,"price_display":"15.64","price_state":"stated","total_value":78200.0,"total_display":"78,200.00","total_whole":"78,200","shares_owned_after":943714.0,"shares_owned_after_display":"943,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-02","scope":"insider"},{"id":8665694,"accession":"0001415889-23-014714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-014714","line_url":"/filing/0001415889-23-014714#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":12.05,"price_display":"12.05","price_state":"stated","total_value":301250.0,"total_display":"301,250.00","total_whole":"301,250","shares_owned_after":948714.0,"shares_owned_after_display":"948,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-31","filed_date":"2023-11-02","scope":"insider"},{"id":8059797,"accession":"0001415889-23-013898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-013898","line_url":"/filing/0001415889-23-013898#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":12.41,"price_display":"12.41","price_state":"stated","total_value":310250.0,"total_display":"310,250.00","total_whole":"310,250","shares_owned_after":973714.0,"shares_owned_after_display":"973,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-29","filed_date":"2023-10-03","scope":"insider"},{"id":8665614,"accession":"0001415889-23-012922","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-012922","line_url":"/filing/0001415889-23-012922#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":11.62,"price_display":"11.62","price_state":"stated","total_value":116200.0,"total_display":"116,200.00","total_whole":"116,200","shares_owned_after":998714.0,"shares_owned_after_display":"998,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-05","scope":"insider"},{"id":8665612,"accession":"0001415889-23-012922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-012922","line_url":"/filing/0001415889-23-012922#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":9.36,"price_display":"9.36","price_state":"stated","total_value":140400.0,"total_display":"140,400.00","total_whole":"140,400","shares_owned_after":1008714.0,"shares_owned_after_display":"1,008,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-09-05","scope":"insider"},{"id":9287221,"accession":"0001415889-23-012898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-012898","line_url":"/filing/0001415889-23-012898#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":152100.0,"total_display":"152,100.00","total_whole":"152,100","shares_owned_after":1023714.0,"shares_owned_after_display":"1,023,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-09-05","scope":"insider"},{"id":8127723,"accession":"0001415889-23-012360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-012360","line_url":"/filing/0001415889-23-012360#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.14,"price_display":"10.14","price_state":"stated","total_value":152100.0,"total_display":"152,100.00","total_whole":"152,100","shares_owned_after":1023714.0,"shares_owned_after_display":"1,023,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-17","scope":"insider"},{"id":8304712,"accession":"0001415889-23-009522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-009522","line_url":"/filing/0001415889-23-009522#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.3,"price_display":"6.30","price_state":"stated","total_value":63000.0,"total_display":"63,000.00","total_whole":"63,000","shares_owned_after":1038714.0,"shares_owned_after_display":"1,038,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"},{"id":8087326,"accession":"0001415889-23-009406","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-009406","line_url":"/filing/0001415889-23-009406#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.295,"price_display":"6.30","price_state":"stated","total_value":31475.0,"total_display":"31,475.00","total_whole":"31,475","shares_owned_after":1048714.0,"shares_owned_after_display":"1,048,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":8087324,"accession":"0001415889-23-009406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-009406","line_url":"/filing/0001415889-23-009406#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":6.045,"price_display":"6.04","price_state":"stated","total_value":30225.0,"total_display":"30,225.00","total_whole":"30,225","shares_owned_after":1053714.0,"shares_owned_after_display":"1,053,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":4446789,"accession":"0001415889-21-005622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005622","line_url":"/filing/0001415889-21-005622#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNOLOGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":24.76,"price_display":"24.76","price_state":"stated","total_value":9904.0,"total_display":"9,904.00","total_whole":"9,904","shares_owned_after":1051146.0,"shares_owned_after_display":"1,051,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-12-01","scope":"insider"},{"id":5358737,"accession":"0001415889-21-004934","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-21-004934","line_url":"/filing/0001415889-21-004934","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNOLOGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":27.982854166666666,"price_display":"27.98","price_state":"stated","total_value":335794.25,"total_display":"335,794.25","total_whole":"335,794","shares_owned_after":1056101.0,"shares_owned_after_display":"1,056,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-21","scope":"insider","n_lines":2},{"id":5447742,"accession":"0001415889-21-004513","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-004513","line_url":"/filing/0001415889-21-004513#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNOLOGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":26.3,"price_display":"26.30","price_state":"stated","total_value":315600.0,"total_display":"315,600.00","total_whole":"315,600","shares_owned_after":1063546.0,"shares_owned_after_display":"1,063,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-21","scope":"insider"},{"id":4198923,"accession":"0001415889-21-004029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-004029","line_url":"/filing/0001415889-21-004029#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNOLOGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":24.97,"price_display":"24.97","price_state":"stated","total_value":299640.0,"total_display":"299,640.00","total_whole":"299,640","shares_owned_after":1075546.0,"shares_owned_after_display":"1,075,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-20","scope":"insider"},{"id":4862491,"accession":"0001415889-21-003664","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-21-003664","line_url":"/filing/0001415889-21-003664#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNOLOGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4123.0,"shares_display":"4,123","price_per_share":25.63,"price_display":"25.63","price_state":"stated","total_value":105672.49,"total_display":"105,672.49","total_whole":"105,672","shares_owned_after":1087546.0,"shares_owned_after_display":"1,087,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-21","scope":"insider"},{"id":4862487,"accession":"0001415889-21-003664","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-003664","line_url":"/filing/0001415889-21-003664#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNOLOGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7877.0,"shares_display":"7,877","price_per_share":24.83,"price_display":"24.83","price_state":"stated","total_value":195585.91,"total_display":"195,585.91","total_whole":"195,586","shares_owned_after":1091669.0,"shares_owned_after_display":"1,091,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-21","scope":"insider"},{"id":4155948,"accession":"0001415889-21-003129","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-21-003129","line_url":"/filing/0001415889-21-003129#line-3","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNOLOGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9410.0,"shares_display":"9,410","price_per_share":24.54,"price_display":"24.54","price_state":"stated","total_value":230921.4,"total_display":"230,921.40","total_whole":"230,921","shares_owned_after":1102136.0,"shares_owned_after_display":"1,102,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-21","scope":"insider"},{"id":4155945,"accession":"0001415889-21-003129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-21-003129","line_url":"/filing/0001415889-21-003129#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":"0001831410","owner_name":"Harmon Cyrus","owner_display_name":"Harmon Cyrus","owner_url":"/insider/0001831410","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF TECHNOLOGY OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1990.0,"shares_display":"1,990","price_per_share":25.59,"price_display":"25.59","price_state":"stated","total_value":50924.1,"total_display":"50,924.10","total_whole":"50,924","shares_owned_after":1100146.0,"shares_owned_after_display":"1,100,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-21","scope":"insider"}],"collapsed":true,"next_cursor":"2021-06-18|4155945","ledger_fault":false,"count":{"value":51,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":51},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001750284","name":"Olema Pharmaceuticals, Inc.","url":"/issuer/0001750284","role":"Director, Officer (CHIEF TECHNOLOGY OFFICER)","n_filings":31,"first_seen":"2021-06-21","last_seen":"2026-07-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001831410","retrieved_at":"2026-08-24T21:23:59+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}